Home JournalsJournal Details
ISSN: 0161-5505 eISSN: 1535-5667 CAS Zone: Medicine (Zone 1) No

JOURNAL OF NUCLEAR MEDICINE

Abbr. J NUCL MED ·UNITED STATES ·Frequency Monthly ·Avg. articles/yr 329 articles
9.1
Latest IF
10.70%
Self-citation
很难
Submission difficulty
Avg. 1.0 months
Review cycle
About Journal

JOURNAL OF NUCLEAR MEDICINE（ISSN 0161-5505）是一本专注于核医学领域的国际学术期刊，由美国核医学与分子影像学会（SNMMI）出版，出版地为美国，出版周期为月刊。该期刊的影响因子较高，属于SCI收录期刊，并在中科院分区中通常位列医学或核医学领域的较高分区。它不是开放获取（OA）期刊。该杂志的发文特点集中在核医学与分子影像学的前沿研究，包括放射性药物开发、影像技术应用、疾病诊断与治疗等方向，尤其注重临床转化研究。其质量较高，审稿严格，学术声誉良好，但投稿竞争激烈，拒稿率较高，且版面费可能较贵，非OA模式可能限制部分读者获取全文。

IF Trend
Recent Articles
From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX–Targeted [ <sup>68</sup> Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [ <sup>18</sup> F]FDG PET/CT 2026-09-17
Executive Summary: SNMMI/EANM/ACNM/ANZSNM Procedure Standard/Procedure Guideline for Ventilation–Perfusion Pulmonary Scintigraphy 2026-09-17
Beta Atlas: Charting Global Production of Nonconventional β <sup>−</sup> -Emitters for Targeted Radiopharmaceutical Therapy—Part 1 2026-09-17
From Bench to Bedside: A Critical Appraisal of Somatostatin Receptor Antagonists in the Theranostic Management of Neuroendocrine Neoplasms 2026-09-17
Recurrence: A Patient’s Perspective on How Nuclear Medicine Creates Hope Through Clarity 2026-09-17
Comparison of Expert Reads Versus Local Clinical Reads of Amyloid PET Scans in the IDEAS Study 2026-09-10
Is Dedicated Breast PET Really Happening? 2026-09-10
Diagnostic Performance of [ <sup>68</sup> Ga]Ga-DPI-4452 PET/CT in Patients with Clear Cell Renal Cell Carcinoma: A Prospective Trial 2026-09-10
Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma 2026-09-10
Regional Blood Flow Assessment in Total-Body Organs with Improved Temporal Resolution Using Long–Axial-Field-of-View PET 2026-09-10
Visualizing Persistent Inflammation and Occult Infections in Nonrecovering ICU Patients with [ <sup>18</sup> F]FDG PET/CT: VIPER Study Protocol 2026-09-10
Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy 2026-09-10
Lesion Detection and Uptake Patterns of [ <sup>18</sup> F]F-ATD001 PET/CT and [ <sup>18</sup> F]FDG PET/CT in Triple-Negative Breast Cancer 2026-09-10
Quantitative Thresholds on <sup>18</sup> F-DCFPyL PET for Determining Malignancy in Prostate Cancer with Pathologic Correlation 2026-09-10
Targeted RPT of CEACAM5-Expressing Human Xenografts Using an Albumin-Binding Domain–Fused C9 Affibody: Proof-of-Principle Study 2026-09-10
PSMA PET/CT and Multiparametric MRI Before Prostate Biopsy 2026-09-03
Radioiodine Spill–Induced Radiation Dermatitis 2026-09-03
Reply to “Cost-Effectiveness of <sup>177</sup> Lu-PSMA-617 Versus Cabazitaxel: Accounting for Real-World and Health Equity Considerations” 2026-09-03
A Conversation Between Stefano Fanti and Johannes Czernin 2026-09-03
Cost-Effectiveness of <sup>177</sup> Lu-PSMA-617 Versus Cabazitaxel: Accounting for Real-World and Health Equity Considerations 2026-09-03
Journal Info
ISSN
0161-5505
Abbr.
J NUCL MED
Country/Region
UNITED STATES
Frequency
Monthly
CAS Zone
Medicine (Zone 1)
Open Access
No
Research Area
Medicine - 核医学
Coverage
Science Citation Index
Sub-categories
RADIOLOGYNUCLEAR MEDICINE & MEDICAL IMAGING核医学1区
Submission & Homepage
Submit Homepage
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2